Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890

Disease

Cancer 2 | 2,346
active Crohn's disease 2 | 918
colon cancer 2 | 1,475
gastric cancer 2 | 430
lung cancer 2 | 4,466
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
primitive neuroectodermal tumor 2 | 3,031
psoriasis 2 | 6,685
ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO 1 | 1
Amyotrophic Lateral Sclerosis 1 | 431
Autistic Disorder 1 | 320
Breast cancer 1 | 3,094
Carcinoma 1 | 2,147
Cardiovascular system disease 1 | 194
Child Development Disorders, Pervasive 1 | 55
Congenital diaphragmatic hernia 1 | 43
Congenital heart disease 1 | 63
Epilepsy 1 | 346
Gas gangrene 1 | 15
HIV Infections 1 | 100
Intellectual disability 1 | 573
Li-Fraumeni Syndrome 1 | 13
Lipoma 1 | 19
Liposarcoma, Dedifferentiated 1 | 3
Liposarcoma, well differentiated 1 | 3
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20 1 | 1
Male infertility 1 | 170
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Myocardial Infarction 1 | 126
Myopathy 1 | 128
Neoplastic Cell Transformation 1 | 81
Osteoporosis 1 | 257
PITT-HOPKINS SYNDROME 1 | 21
Parkinson's disease 1 | 364
Peripheral Neuropathy 1 | 303
Platelet mean volume finding 1 | 31
Precancerous Conditions 1 | 69
Prenatal Exposure Delayed Effects 1 | 9
Progressive relapsing multiple sclerosis 1 | 18
Prostatic Neoplasms 1 | 471
Rhabdomyosarcoma, Embryonal 1 | 3
Status Epilepticus 1 | 85
Stereotypic movement disorder 1 | 6
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
active ulcerative colitis 1 | 477
acute quadriplegic myopathy 1 | 1,157
astrocytic glioma 1 | 2,241
atypical teratoid / rhabdoid tumor 1 | 4,369
atypical teratoid/rhabdoid tumor 1 | 1,095
autosomal dominant Emery-Dreifuss muscular dystrophy 1 | 499
dermatomyositis 1 | 933
ependymoma 1 | 2,514
glioblastoma 1 | 5,572
glioblastoma multiforme 1 | 347
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
medulloblastoma 1 | 1,524
nasopharyngeal carcinoma 1 | 1,056
nephrosclerosis 1 | 329
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
oligodendroglioma 1 | 2,849
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
periodontitis 1 | 269
pilocytic astrocytoma 1 | 3,086
primary Sjogren syndrome 1 | 789
subependymal giant cell astrocytoma 1 | 2,287

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444
Respiratory system 2 | 17,484

Target Family

Transcription Factor 2 | 1,400
Enzyme 1 | 4,146

Grant Application

5K08HL003805-04 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
E3 ubiquitin-protein ligase Mdm2 MDM2 Tchem Enzyme -3.38438 2174.7 1062
Myoblast determination protein 1 MYOD1 Tbio Transcription Factor -3.13423 1281.5 563
Myocyte-specific enhancer factor 2C MEF2C Tbio Transcription Factor -2.22869 164.9 849